Emerging economy drugmakers face lurking challenge

Asian economies have opened up and policymakers are taking care of their manufacturing industries, writes political economist Dani Rodrik. "When economies develop and become richer, manufacturing inevitably becomes less important. But if this happens more rapidly than workers can acquire advanced skills, the result can be a dangerous imbalance between an economy's productive structure and its workforce." Column

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.